Anvi Pharmaceuticals Inc NDCs and Package Codes
This page lists NDC package records associated with labeler code 87519 (Anvi Pharmaceuticals Inc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
3
Package NDCs
3
Products
3
Active listings
0
Discontinued
3
Ingredients
0
Therapeutic classes
3
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 3 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Benzonatate 150 mg/1 CAPSULE | 87519-0111-90 | — | On market | View → |
| Imiquimod 37.5 mg/g CREAM | 87519-0004-75 | — | On market | View → |
| LYVISPAH baclofen 10 mg/1 GRANULE | 87519-0003-90 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.